ARN14 Feb. 2002 JSPS visit Showa University National “prescribing rule”;  Newly prescribed drugs is provided for not more than 2 weeks  Long term medications.

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Medication Management
22nd European Social Services Conference – Rome, 7-9 July 2014 Social and healthcare integration Lazio Regional Authority strategy to support people with.
MEDICINES SELECTION & FORMULARY MANAGEMENT
Abstract The Knowledge, Perceptions, and Practice of Pharmacovigilance among Community Pharmacists in Lagos State, Southwest Nigeria Oreagba, Ibrahim Adekunle.
ECONOMIC ASSESSMENT OF IMPLEMENTATION TREATMENT GUIDELINES OF HYPERTENSION IN OUT-PATIENT PRACTICE Kulmagambetov IR Karaganda State Medical Academy, Kazakhstan.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Pharmaceutical Services Unit Essential Medicines Management
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
1 Drug and Therapeutics Committee Session 10. Standard Treatment Guidelines.
National Mental Health Programme. Govt of India integrated mental health with other health services at rural level. It is being implemented since 1982.
Perspectives and achievements with Rational Pharmacotherapy Meeting under Danish EU presidency Implementation of Rational Pharmacotherapy Copenhagen, November.
Clinical Pharmacy Basma Y. Kentab MSc..
1 WHO Programme for International Drug Monitoring & the Uppsala Monitoring Centre Shanthi Pal and Mary Couper Quality Assurance and Safety of Medicines.
ARN14 Feb JSPS visit Showa University RUD useful references; Rational Drug Use: Consumer Education and Information Estimating Drug Requirements:
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
The 2010 World Programme on Population and Housing Censuses Paul Cheung, Director United Nations Statistics Division.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Introduction To Pharmacy Practice
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Rational Use of Drug Ali Abad hospital April 12 th, 2005.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Clinical Pharmacy Part 2
WHO Perspective on Medicine Patents and FTAs Asian Regional Workshop on FTAs August, 2005, Kuala Lumpur, Malaysia Dr Zafar Mirza Regional Adviser,
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,
Margarit MELIKYAN Drug Utilization Research Group PO, Armenia, National Institute of Health Access to and Use of Medicines by Households in Armenia: Impact.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
Misoprostol for PAC Task Force Presentations PAC Consortium Meeting May 26, 2009.
University of Wisconsin Pain & Policy Studies Group World Health Organization Collaborating Center for Pain Policy and Palliative Care Action Plan for:
ABSTRACT Title: Developing National Formularies Based on the WHO Model Formulary Authors: Tisocki K 3, Laing RL 1, Hogerzeil H 1, Mehta DK 2, Ryan RSM.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Promoting Drug and Therapeutics Committees in the Developing World
ARN14 Feb JSPS visit Showa University Petronas Twin Tower – K.L.C.C.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
MODEL POLICY FRAMEWORK FOR E-WASTE MANAGEMENT IN THE EAST AFRICAN REGION Nakiguli Helen Cynthia, Uganda Communications Commission,
SARPAM Southern African Regional Programme for Access to Medicines and Diagnostics Presentation to Botswana TRIPS and Access to Medicines workshop 26 March.
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Selection of essential medicines Richard Laing and Deidre Dimancesco TBS 2011 Department of Essential Medicines & Pharmaceutical Policies TBS 2008.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Agenda BupaPrivate and Confidential Implementing a training and accreditation scheme for TTA pre-pack dispensing R Betmouni, N Gillani Pharmacy Department,
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
Questions to Committee about Potential Cancer Risk with Use of Topical Immunosuppressants (Calcineurin Inhibitors) Question 1: Messages about Risk A. Based.
African Centre for Statistics United Nations Economic Commission for Africa Proposed Regional Medium-term Civil Registration and Vital Statistics Plan.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Promoting Drug and Therapeutics Committees in the Developing World
WHO Medicines Work in Countries: The Kenya Example
Expanding ARV treatment in developing countries: Issues and Prospects
Musculoskeletal Health in Europe
Introduction to Clinical Pharmacy
Quality Assurance and Safety of Medicines
Lazio Regional Authority strategy
68.3 million errors (28% of total) cause moderate or serious harm
Kandeke C, Chibuta C, Banda D
Adherence, attitude to Standard Treatment Guidelines in clinical practice at tertiary care hospitals in Delhi State 1Sangeeta Sharma, 2Sharma KK, 3Sethi.
Regulation of Medical Products & Patient Safety- A Narrative Review
Pharmacy practice and the healthcare system Ola Ali Nassr
Evaluating International Drug and Therapeutics Committees Courses in the Developing World
Pharmaceutical care plans Ola Ali Nassr
Presentation transcript:

ARN14 Feb JSPS visit Showa University National “prescribing rule”;  Newly prescribed drugs is provided for not more than 2 weeks  Long term medications is provided for not more than 3 months  Other medications is provided for not more than 1 month  OCPs is provided for not more than 6 months.

ARN14 Feb JSPS visit Showa University Lazaros et. al. JAMA 279: 1200, 1998 Meta analysis (39 prospective studies in Toronto)  Serious ADRS requiring hospitalization or causing permanent disability or death = 6.7%  Fatal ADRS = 0.32% =  ADR  th leading cause of death.

ARN14 Feb JSPS visit Showa University HUSM experience Errors in prescribing process;  Wrong dose  Wrong frequency  Wrong duration  Wrong administration technique

ARN14 Feb JSPS visit Showa University Patient factors:  Failure to take drug or partial compliance  Taking more drugs than instructed  Self-treatment  Wrong technique of administration  Taking expired drugs

ARN14 Feb JSPS visit Showa University Explanations:  Lack of knowledge  Influenced by others  Negative attitudes  Own experience  Own perceptions  Difficult/complicated regimen  Extremes of age and need for assistance

ARN14 Feb JSPS visit Showa University 2 nd P-Drug workshop 1999

ARN14 Feb JSPS visit Showa University WHO Organisational Structure Yasuhiro Suzuki Jonathan Quick

ARN14 Feb JSPS visit Showa University WHO's mission in medicines for 2000–2003 includes four main objectives: Policy Access Quality and Safety Rational Use of Drugs

ARN14 Feb JSPS visit Showa University WHO’s Mission in Essential Drugs and Medicines Policy To help save lives and improve health by: closing the huge gap between the potential that essential drugs have to offer and the reality that for millions of people – particularly the poor and disadvantaged -- medicines are unavailable, unaffordable, unsafe or improperly used.

ARN14 Feb JSPS visit Showa University WHO’s Mission in Essential Drugs and Medicines Policy (cont.) The Organization works to fulfill its mission in essential drugs and medicines policy by: providing global guidance on essential drugs and medicines, and working with countries at their request to implement national drug policies to ensure equity of access to essential drugs, drug quality and safety, and rational use of drugs.

ARN14 Feb JSPS visit Showa University Rational Use of Drugs Ensure therapeutically sound and cost-effective use of drugs by health professionals and consumers

ARN14 Feb JSPS visit Showa University Rational Use of Drugs Improving the use of drugs by health workers and the general public is crucial to: reduce morbidity and mortality from communicable and non- communicable diseases, and contain drug expenditure.

ARN14 Feb JSPS visit Showa University Rational Use of Drugs A sound rational drug use programme in any country has three elements: Rational drug use strategy and monitoring - advocating rational drug use, identifying and promoting successful strategies, and securing responsible drug promotion. Rational drug use by health professionals Rational drug use by consumers

ARN14 Feb JSPS visit Showa University Rational drug use strategy and monitoring Support countries in implementing and monitoring a national strategy to promote rational use of drugs by health professionals and consumers.

ARN14 Feb JSPS visit Showa University Rational drug use by health professionals Develop national standard treatment guidelines, essential drugs lists, educational programmes and other effective mechanisms to promote rational drug use by health professionals.

ARN14 Feb JSPS visit Showa University Priorities for global guidance for 2000–2001 –Review of the development, dissemination and use of the WHO Model List of Essential Drugs –Review and dissemination of WHO Standard Treatment Guidelines –Training materials and curriculum review for undergraduate training –Guidelines for Drugs and Therapeutics Committees –International training materials and training in public education –International training materials and training in pharmaco- economics –Regional rational drug use training courses in French and Spanish (?for African countries) –Standard indicators and protocols to monitor drug promotion practices

ARN14 Feb JSPS visit Showa University What are essential drugs? "Essential drugs are those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in the appropriate dosage forms, and at a price that individuals and the community can afford."

ARN14 Feb JSPS visit Showa University History of Essential Drug List 1897 – Aspirin was introduced as the first synthetic pharmaceutical 1941 – Introduction of first modern antibiotics i.e Penicillin 1943 – First commercial antimalarial 1944 – First antituberculous drug 1950’s – Introduction of oral contraceptives, antidiabetics and antipsychotics 1977 – WHO published first model list of Essential drugs (208) 1997 – WHO’s 10 th model list of essential drugs (306) The 11th Model List -- describing just over 300 drugs -- was revised in November 1999 and published in December N.B: Malaysia’s EDL contains 419 items and a supplemental list

ARN14 Feb JSPS visit Showa University Progress on PRUD activities; Extensive research has shown that standard treatment guidelines, essential drugs lists and formularies do promote rational prescribing of drugs by prescribers. By the end of 1999, 157 countries had an essential drugs list. 135 countries have developed national treatment guidelines, of which 112 have been updated in the last five years. There are now more than 100 national formularies, By the end of 1999, 88 countries in all six WHO regions had introduced the essential drugs concept into curricula for medicine and pharmacy students.

ARN14 Feb JSPS visit Showa University Progress on PRUD activities; (cont.) The WHO Guide to Good Prescribing has proved to be another invaluable tool. Translated into 18 languages and now available on at least six different web-sites, it continues to be one of the Organization’s most successful publications. Primarily intended for undergraduate medical students who are about to enter the clinical phase of their studies, it provides step-by-step guidance on the process of rational prescribing.WHO Guide to Good Prescribing

ARN14 Feb JSPS visit Showa University Progress on PRUD activities; (cont.) The WHO Model List of Essential Drugs, and regional and international rational drug use courses, form a large part of ongoing WHO efforts to improve drug use by health professionals.WHO Model List of Essential Drugs International training courses for university teachers in problem-based pharmacotherapy teaching are held every year in Europe, Africa and Latin America. Two randomized controlled trials with over ten centres in developed and developing countries have shown that the teaching methods transfer lasting skills in rational prescribing.

ARN14 Feb JSPS visit Showa University Progress on PRUD activities; (cont.) WHO Monographs on Selected Medicinal Plants :WHO Monographs on Selected Medicinal Plants are also doing much to promote rational drug use, but in the area of traditional medicine. The Monographs were recently recommended by the European Commission to Member States as an authoritative reference.

ARN14 Feb JSPS visit Showa University Other Activities:  International Conference of Drug Regulatory Authorities (ICDRA)  International Conference on Harmonisation (ICH)  WHO Programme for International Drug Monitoring  UMC (Uppsala monitoring centre) – the Global Intelligence Network for Benefits and Risks in Medicinal Products  The WHO Collaborating Centre for Drug Statistics Methodology